Oragenics, Inc. (OGEN): Advancement of COVID-19 Vaccine Continues; IND Filing in 2021
Wed Apr 21, 2021 2:47 pm
Oragenics, Inc. (OGEN): Advancement of COVID-19 Vaccine Continues; IND Filing in 2021
COVID-19 Vaccine Development ContinuesOragenics, Inc. (NYSE:OGEN) is developing TerraCoV2, a vaccine candidate against SARS-CoV-2 (the virus that causes COVID-19) that is licensed from the National http://www.forexmarket.site/listing-oragenics-inc-ogen-1715.html
COVID-19 Vaccine Development ContinuesOragenics, Inc. (NYSE:OGEN) is developing TerraCoV2, a vaccine candidate against SARS-CoV-2 (the virus that causes COVID-19) that is licensed from the National http://www.forexmarket.site/listing-oragenics-inc-ogen-1715.html
- Oragenics COVID-19 Related Deal Pushes The Stock Higher
- Official: Africa needs COVID-19 vaccine for 60% in 2-3 years
- AstraZeneca Cooperation with Russia on COVID-19 Vaccine 2020-12-11
- Biotech Stocks To Buy Beyond Covid Vaccine Development Before Report
- COVAX Statement on WHO Emergency Use Listing for AstraZeneca/Oxford COVID-19 Vaccine
Permissions in this forum:
You cannot reply to topics in this forum